ANNUAL REPORT FOR THE PERIOD ENDING FEB 2023 ROBIN CANCER TRUST we save five& ROBIN CANCER TRUST TAlklMG SOIIOGKS SAVES LIVES
OUR VISION Ourvision is to reach every young person in the UK with our life-saving cancer campaigns. OUR MISSION Our mission is to stop young adults dying from germ cell cancer. OUR HOPE Our hope is no other family has to go through what we did. OUR VALUES RESPECT: Not only for the important work we undertake but also for the people who support our mission. We believe in open, honest and empathetic communication between ourselves and to our community. CREATIVITY: We are a small team with a big vision- to drive the changewe want to see in the world, we must innovate, disrupt and experiment. TRUST: We are accountable to each other & our beneficiaries. We are responsible for upholding these values and the quality of work we undertake- and we will do so with integrity at all times. REG. CHARITY NO, 1148999
OUR IMPACT EDUCATE: We educate young people to give them the best chance of surviving germ cell cancer. ENGAGE: We engage young people with humour to break the stigma of talking about germ cell cancer. EMPOIIER: We empower young people affected by germ cell cancer to thrive. OUR HISTORY Since 2012. we have reached tens of millions of people online. engaged with hundreds of thousands of people in the community. and delivered life-saving educational talks to over100.000 young adults in schools. colleges & businesses across the U The Robin Cancer Trust was founded in 2012 by the Freeman family following the untimely death of their son and brother. Robin Freeman, aged just 24. Robin inspires us to raise awareness, reduce embarrassment and save young lives through the early detection of germ cell cancers. BOARD OF TRUSTEES Sara Hawkins, Interim Chair Mark Freeman. Founder & Treasurer Claire Neal John Cass Jacob Clark Craig Hargreaves Kerry-Ann Jervis Scott
MESSAGE FROM THE CHAIR & CEO The past year has seen increased challenges for both the charity sector and the germ cell concer community ocross the UK. Post-pandemic pressure on the NHS, and continued covid-restrictions. have highlighted the need forourvital worl whilst the cost-of-living crisis has strained income and tightened budgets. However. we have worked diligently to face these issues head-on - ensuring we listen to our community and continue to advocate for them and represent them during this incredibly difficult time. Throughout the year we saw an increaso in our incredible community fundraisers taking on events and challenges in aid of our lifsavIng cancer campoigns! We also saw our events continue to grow. with increased attendance and revenue. Partnerships and collaborations have been a key aspect of our growth, helping raise vital funds and increase our reach across the UK. We took great strides in expanding our education and awareness programmes this year- creating several videos and resources for a wide variety of audiences and communities. We attended festivals. fresher's fairs. and pride events - helping us achieve our goal of'awareness for all.! We also increased our liftrsaving educational talks. reaching thousands of students with our testicular and ovarian cancer information- receiving incredible feedback from students and teachers alike. As we continue to grow our reach and impact across the UK, we will ensure that we put our culture at the forefront of everything we do- staying true to our values as our work evolves. Our heartfelt thanks go out to our amazing staff team whose passion and dedication drive our lif*saving work in the community- along with our Board of Trustees for their time. knowledge. and expertise. Lastly, our etemal gratitude to our donors, fundraisers, volunteers, and ambassadors for helping us drive education. engagement. and empowerment to the germ cell cancer community across the UK. You are the heart and soul of our charity, and we couldn't do it without YOLL We are so excited to be on this journey with you all - and can't wait to explore the next12 months with you! SARA HAWKINS. INTERIM CHAIR TOBY FREEMAN, CEO
IIE SAVE LIVES ROBIN CANCER TRUST
•• IkiMG 3QUQ¢kS AIKING so0[ TIIIG SAVESUVES SAvtsuve¥ SAVESIIVES EDUCATE This year we reached thousands ofstudents with our lif*saving educational talks in schools. colleges and universities across the region. We delivered our Cancer Education Programme both in-person and virtually. to make our information as accessible as possible. Our Fresher's Fair program was a huge sucess, delivering our testicular and ovarian cancer awareness information to hundreds of students at a vital time in their lives. As part of our offering to educational establishments. we have also created several inclusive and representative resources, as part of our pledge to bring 'awareness to all,. • Afterattending our talK 95% of students feel more informed ofthe signs & symptomsofgerm cell cancer, and 85%feel morecomfortable visiting a doctor. "Wow.l One of the most informative and engaging sessions I have ever attendod. Such an important topic approached in a sensitivo yet fun manner. I would definitely recommendl. - Student, Sixth Fomi College
ENGAGE From launching Testicular Cancer Awareness Month by creating the world's largest pair of (digital) testicles. to engaging over 300 amazing creatives with our cancer campaigns via One Minute Briefs. to attending festivals, events. and pride celebrations across the region - this may have been our biggest and ballsiest year ever! We reached local. regional. and national press with our campaigns this year-as we strive towards our vision of reaching every young person in the UK with our life-saving cancer campaigns. Huge thanks to all our partners and collaborators for helping us reach new audiences all across the UK- along with all the incredible volunteers who help us engage with our community. • We reached millionsofyoung adults online, and tens ofthousand ot people in the community. with ouraward-winning #TalkingBollocks and #Notovaryacting campaigns .1 had the best timo volunteeringl A truly groat day out in the community talking bollocks and raising awarenessl. - James, Volunteer
// EMPOWER This year we worked tirelessly to expand our Thriver Program nationally, allowing anyone. anwhere in the UK, access to our free cancer support packs. Alongside our Thriver Group. we have carefully curated and created resources for newly diagnosed individuals. We are incredibly grateful to our partner organisations and hospitals for working alongside us to ensure everyone affected by germ cell cancer in the UK receives the support they need. We have continued to listen to our community, putting their experience at the forefront of our services- and have given then a platform to tell their story, raw and uncut, via our online blog. • We sentout dozens offreeThriverCancer Support Packs to support ourcommunity during the hardest time oftheir life. "The most amazing packagel Thank you so much Robin Cancer Trust. this has mado my day. - Jayne. Ovarian Cancer Thriver
1049 EVENTS We've had yet another incredible year of events- and we're so proud of every single one of our supporters who organised. entered. or fundraised in aid of us! From half-marathon eff orts. to threpeak challenges. to walking pier- to-pier in their pants- our supporters have done it alll Our events offering continues to grow. allowing our supporters a wide- range of experiences- from walks, runs. treks. skydives and everything in- between! Our fantastic staff team ensure that everyone feels valued and supported, whatever challenge or event they take part in. • Thankyou to all ouramazing fundraisers. donors. partners and supportersfor helping us raise vital funds for germ cell cancer awareness, education, and support! °If you're looking to raise money for The Robin Cancer Trust. just know that you'll be very well looked after and you'll have a great time doing itr - Jordan. Founder. Gt. Dunmow Soapbox Race
THE NEXT 12 MONTHS Our organisational goals for the next l2-months are to increase the reach and impact of our life-saving cancer campaigns, and expand our education. awareness. and suppport programmes so that we can support as many people as possible across the UK. To achieve this, we will be focusing on four key areas: EDUCATION: The next steps in our Cancer Education Programme include the creation of dedicated online resources and workshops for educational establishments. We will also be increasing our presence in schools, colleges and universities in the region. AIIARENESS: We will working closely with partners to create diverse, inclusive and representative resources. to help us achieve our goal of 'awareness for all'_ helping us reach communities and audiences all across the UK. We will also be launching an Ambassador programme to help us engage with our community, whilst spreading our important messages to a more national audienca. SUPPORT: We will continue to advocate for, and empower. our community through Co-created resources to support those affected by germ cell cancer. We will be expanding our Thriver Pack offering through our national partners, creating an online forum for the germ cell cancer community, and putting lived-experience at the forefront of our support programmes. INCOME GENERATION: To underpin our liftrsaving work in the community, we must continue to diversify and grow our fundraising portfolio sustainably. We have made great strides in this area, following the acquisition of the Colchester Half Marathon. along with the increased focus on Trusts & Foundations fundraising, and the creation of several in-person and virtual events for our supporters to engage with.
THANK You! There are far too many people to mention specifically, but we want to take this opportunity to thank every single donor. fundraiser. volunteer, business, organisation, and partner who have supported The Robin Cancer Trust over the past12-monthsl Thanks to you we are able to continue to support the UK'S germ cell cancer community- and to deliver lif*saving cancer awareness. education, and support to young adults all across the UK. In short: YOU ARE AMAZEBALLS! ROBIN CANCER TRUST
CONTACT US IIE'D LOVE TO HEAR FROM YOUI ROBIN CANCER TRUST we save lives. The Robin Cancer Trust, 29 Queens Road. Wivenhoe. Essex. C07 9JJ vvww.therobincancertrust.org info@therobincancertrust.org @rctcharity #TalkingBollocks #Notovaryacting ROBIN CANCER TRUST ROBIN CANCER TRUST
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
Charity registration number 1148999
THE ROBIN CANCER TRUST
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2023
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
LEGAL AND ADMINISTRATIVE INFORMATION
| Trustees | Mr M Freeman (Chair of Trustees) | |
|---|---|---|
| Ms K Jervis-Scott (Treasurer) | (Appointed 1 January 2023) | |
| Mr J Cass | (Appointed 1 August 2022) | |
| Mr C Hargreaves | (Appointed 1 January 2023) | |
| Mrs S Hawkins | ||
| Mrs C Pearce | ||
| Chief Executive Officer | Mr T Freeman | |
| Charity number | 1148999 | |
| Principal address | 29 Queens Road | |
| Wivenhoe | ||
| Colchester | ||
| CO7 9JJ | ||
| Independent examiner | Daniel Insley BA ACA | |
| The Old Exchange | ||
| 64 West Stockwell Street | ||
| Colchester | ||
| Essex | ||
| CO1 1HE | ||
| Bankers | Metro Bank PLC | |
| One Southampton Row | ||
| London | ||
| WC1B 5HA |
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST CONTENTS
| Page | |
|---|---|
| Trustees' report | 1 - 2 |
| Independent examiner's report | 3 |
| Statement of financial activities | 4 |
| Balance sheet | 5 |
| Notes to the financial statements | 6 - 13 |
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
TRUSTEES' REPORT
FOR THE YEAR ENDED 28 FEBRUARY 2023
The trustees present their annual report and financial statements for the year ended 28 February 2023.
The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities Act 2011 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).
Objectives and activities
Our Vision
To stop young adults dying from germ cell cancer.
Our Mission
To reach every young person in the UK with our life-saving cancer campaigns.
Our Hope
No other family has to go through what we did.
Our Impact
We educate young people to give them the best chance of surviving germ cell cancer. We engage young people with humour to break the stigma of talking about germ cell cancer. We empower young people effected by germ cell cancer to thrive.
The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake.
Achievements and performance
over the course of the year we undertook countless activities to raise awareness of germ cell cancer and raise much needed funds with the help of our supporters, volunteers and team members.
Education
Alongside our in-person educational talks, we have developed a library of free digital resources for educational establishments to use for their students - allowing us to reach a national audience with our life-saving message.
Awareness
Our mantra is "awareness for all" because we believe everyone deserves access to our life-saving cancer campaigns.
over the past 12 months we have created, curated and collaborated with partners so that we could reach as many people and communities as possible with our #TalkingBollocks #NotOvaryActing cancer campaigns
Support
Our "Thriver" cancer support packs have continued to help those going through the hardest time of their lives.
We have continued to work alongside our community to empower those people affected by germ cell cancer to thrive. Listening to the experience of others to better shape our services and programmes so we can better serve our beneficiaries and have a positive impact on their lives.
Financial review
At the 28th February 2023 the total reserves of the Charity were £71,908 (2022: £54,972), of which £53,667 (2022: £26,225) were unrestricted funds, and £18,241 (2022: £nil) were restricted funds.
- 1 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY 2023
It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six months expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.
Structure, governance and management
The trustees who served during the year and up to the date of signature of the financial statements were: Mr M Freeman (Chair of Trustees)
Ms K Jervis-Scott (Treasurer) (Appointed 1 January 2023) Mr J Cass (Appointed 1 August 2022) Mr J Clark (Appointed 1 January 2023 and resigned 19 July 2023) Mr C Hargreaves (Appointed 1 January 2023) Mrs S Hawkins Mrs C Pearce
The management of the Charity is the responsibility of the Trustees who are elected under the terms of the Trust Deed.
The Board of Trustees has the power to appoint and remove trustees on a majority basis, with the Chair of Trustees having the casting vote where necessary.
The Board of Trustees have oversight management of the Charity, delegating the operational management to the CEO who is supported by a Community Manager, and marketing, social media, and communications staff. Financial operations are managed by the Treasurer.
The trustees' report was approved by the Board of Trustees.
Mr M Freeman (Chair of Trustees)
19 December 2023
- 2 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF THE ROBIN CANCER TRUST
I report to the trustees on my examination of the financial statements of The Robin Cancer Trust (the charity) for the year ended 28 February 2023.
Responsibilities and basis of report
As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (the 2011 Act).
I report in respect of my examination of the charity’s financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
Your attention is drawn to the fact that the charity has prepared financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn.
I understand that this has been done in order for financial statements to provide a true and fair view in accordance with Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
1 accounting records were not kept in respect of the charity as required by section 130 of the 2011 Act; or
-
2 the financial statements do not accord with those records; or
-
3 the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Daniel Insley BA ACA
The Old Exchange 64 West Stockwell Street Colchester Essex CO1 1HE
Dated: 19 December 2023
- 3 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 28 FEBRUARY 2023
| Unrestricted Restricted funds funds 2023 2023 Notes £ £ Income from: Donations and legacies 3 119,386 21,241 Charitable activities 4 800 - Investments 5 138 - Total income 120,324 21,241 Expenditure on: Raising funds 6 10,441 - Charitable activities 7 111,188 3,000 Total expenditure 121,629 3,000 Net (expenditure)/income for the year/ Net movement in funds (1,305) 18,241 Fund balances at 1 March 2022 54,972 - Fund balances at 28 February 2023 53,667 18,241 |
Total Unrestricted funds 2023 2022 £ £ 140,627 145,549 800 210 138 - 141,565 145,759 10,441 11,911 114,188 105,101 124,629 117,012 16,936 28,747 54,972 26,225 71,908 54,972 |
Total Unrestricted funds 2023 2022 £ £ 140,627 145,549 800 210 138 - 141,565 145,759 10,441 11,911 114,188 105,101 124,629 117,012 16,936 28,747 54,972 26,225 71,908 54,972 |
|---|---|---|
| 145,759 | ||
| 11,911 | ||
| 105,101 | ||
| 117,012 | ||
| 28,747 26,225 |
||
| 54,972 |
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
- 4 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
BALANCE SHEET
AS AT 28 FEBRUARY 2023
| Notes Fixed assets Tangible assets 12 Current assets Debtors 13 Cash at bank and in hand Creditors: amounts falling due within one year 14 Net current assets Total assets less current liabilities Income funds Restricted funds Unrestricted funds |
2023 £ 11,816 106,342 118,158 (46,792) |
£ 542 71,366 71,908 18,241 53,667 71,908 |
2022 £ 660 57,541 58,201 (3,229) |
£ - 54,972 |
|---|---|---|---|---|
| 54,972 | ||||
| - 54,972 |
||||
| 54,972 |
The financial statements were approved by the Trustees on 19 December 2023
Mr M Freeman (Chair of Trustees) Trustee
- 5 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2023
1 Accounting policies
Charity information
The Robin Cancer Trust is a charity, registered with the Charity Commission for England and Wales and is regulated by the Trust Deed dated 14 September 2012.
1.1 Accounting convention
The financial statements have been prepared in accordance with the charity's [governing document], the Charities Act 2011, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.
The charity has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows.
The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.
The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2 Going concern
At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3 Charitable funds
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.
1.4 Income
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.
- 6 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY 2023
1 Accounting policies
(Continued)
1.5 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.
Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.
1.6 Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings 3 Year Straight Line Computers 3 Year Straight Line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.
1.7 Impairment of fixed assets
At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).
1.8 Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
- 7 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY 2023
1 Accounting policies
(Continued)
1.9 Financial instruments
The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial instruments are initially recognised at transaction value and subsequently measured at amortised cost. Financial assets comprise cash at bank and in hand, together with trade and other debtors. A specific provision is made for debts for which recoverability is in doubt. Cash at bank and in hand is defined as all cash held in instant access bank accounts and used as working capital. Financial liabilities held at amortised cost comprise all creditors except social security and other taxes, deferred income and provisions.
1.10 Employee benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11 Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
2 Critical accounting estimates and judgements
In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
- 8 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2023
| 3 | Donations and legacies | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | **Total ** | Unrestricted | ||
| funds | funds | funds | |||
| 2023 | 2023 | 2023 | 2022 | ||
| £ | £ | £ | £ | ||
| Donations and gifts | 119,366 | - | 119,366 | 116,713 | |
| Other Grant Income | - | 21,241 | 21,241 | 28,752 | |
| Gift Aid | 20 | - | 20 | 84 | |
| 119,386 | 21,241 | 140,627 | 145,549 | ||
| 4 | Charitable activities | ||||
| Unrestricted | Unrestricted |
||||
| Funds | Funds | ||||
| 2023 | 2022 | ||||
| £ | £ | ||||
| Sales within charitable activities | 800 | 210 | |||
| 5 | Investments | ||||
| Unrestricted | Total | ||||
| funds | |||||
| 2023 | 2022 | ||||
| £ | £ | ||||
| Interest receivable | 138 | - |
- 9 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2023
6 Raising funds
| **Unrestricted ** | Unrestricted | |
|---|---|---|
| funds | funds | |
| 2023 | 2022 | |
| £ | £ | |
| Fundraising and publicity | ||
| Seeking donations, grants and legacies | 3,598 | 1,009 |
| Advertising | 6,843 | 10,902 |
| Fundraising and publicity | 10,441 | 11,911 |
| 10,441 | 11,911 |
7 Charitable activities
| Unrestricted | Unrestricted |
|
|---|---|---|
| Funds | Funds | |
| 2023 | 2022 | |
| £ | £ | |
| Staff costs | 83,783 | 55,032 |
| Depreciation and impairment | 192 | - |
| Other charitable activities | 6,777 | 48,926 |
| 90,752 | 103,958 | |
| Share of support costs (see note 8) | 13,097 | 255 |
| Share of governance costs (see note 8) | 10,339 | 888 |
| 114,188 | 105,101 | |
| Analysis by fund | ||
| Unrestricted funds | 111,188 | 105,101 |
| Restricted funds | 3,000 | - |
| 114,188 | 105,101 |
- 10 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2023
8 Support costs
| Support costs Governance costs £ £ Insurance 249 - IT Software & Consumables 2,708 - Office Equipment & Consumables 4,687 - Postage, Freight & Courier 324 - General Expenses 2,349 - Travel 915 - Charitable Activities 435 - Bank charges 1,430 - Independent examiners fees - 1,680 Accountancy - 661 Legal and professional - 7,932 Trustee Expenses - 66 13,097 10,339 Analysed between Charitable activities 13,097 10,339 |
2023 £ 249 2,708 4,687 324 2,349 915 435 1,430 1,680 661 7,932 66 |
|---|---|
| 23,436 | |
| 23,436 |
Governance costs includes payments to the independent examiners of £1,680 (2022 - £888).
9 Trustees
None of the trustees (or any persons connected with them) received any remuneration during the year, but 1 of them were reimbursed a total of £66 travelling expenses (2022- none were reimbursed).
10 Employees
The average monthly number of employees during the year was:
| 2023 | 2022 |
|---|---|
| Number | Number |
| 3 | 2 |
- 11 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 28 FEBRUARY 2023
| 10 Employees Employment costs Wages and salaries Social security costs Other pension costs |
(Continued) 2023 2022 £ £ 79,445 53,257 2,513 637 1,825 1,138 83,783 55,032 |
(Continued) 2023 2022 £ £ 79,445 53,257 2,513 637 1,825 1,138 83,783 55,032 |
|---|---|---|
| 55,032 |
There were no employees whose annual remuneration was more than £60,000.
11 Taxation
The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.
12 Tangible fixed assets
| Fixtures and fittings Computers £ £ Cost Additions 179 555 At 28 February 2023 179 555 Depreciation and impairment Depreciation charged in the year 36 156 At 28 February 2023 36 156 Carrying amount At 28 February 2023 143 399 13 Debtors 2023 Amounts falling due within one year: £ Other debtors 9,342 Prepayments and accrued income 2,474 11,816 |
Total £ 734 |
|---|---|
| 734 | |
| 192 | |
| 192 | |
| 542 | |
| 2022 £ 660 - |
|
| 660 |
- 12 -
DocuSign Envelope ID: 0FD86735-2B08-4551-890D-DDE0CA56DBA1
THE ROBIN CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2023
14 Creditors: amounts falling due within one year
| Creditors: amounts falling due within one year | ||
|---|---|---|
| Other creditors Accruals and deferred income |
2023 £ 44,729 2,063 46,792 |
2022 £ 3,229 - |
| 3,229 |
15 Retirement benefit schemes
Defined contribution schemes
The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.
The charge to profit or loss in respect of defined contribution schemes was £1,825 (2022 - £1,138).
16 Analysis of net assets between funds
| Unrestricted funds Restricted funds 2023 2023 £ £ Fund balances at 28 February 2023 are represented by: Tangible assets 542 - Current assets/(liabilities) 53,125 18,241 53,667 18,241 |
Total Unrestricted funds 2023 2022 £ £ 542 - 71,366 54,972 71,908 54,972 |
Total Unrestricted funds 2023 2022 £ £ 542 - 71,366 54,972 71,908 54,972 |
|---|---|---|
| 54,972 |
17 Related party transactions
There were no disclosable related party transactions during the year (2022 - none).
- 13 -